Steven Yatomi-Clarke
Chief Executive Officer at PRESCIENT THERAPEUTICS LIMITED
Net worth: 401 677 $ as of 2024-03-30
Profile
Steven Yatomi-Clarke is currently the Chief Executive Officer, MD & Executive Director at Prescient Therapeutics Ltd.
He started this position in 2016.
Previously, he worked as the Director-Corporate Finance at Patersons Securities Ltd.
He has an undergraduate degree from the University of Melbourne.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-04-30 | 11,195,017 ( 1.39% ) | 401 677 $ | 2024-03-30 |
Steven Yatomi-Clarke active positions
| Companies | Position | Start |
|---|---|---|
| PRESCIENT THERAPEUTICS LIMITED | Chief Executive Officer | 2016-02-14 |
Former positions of Steven Yatomi-Clarke
| Companies | Position | End |
|---|---|---|
Patersons Securities Ltd.
 Patersons Securities Ltd. Investment Banks/BrokersFinance Patersons Securities Ltd. is a brokerage firm that provides brokerage services. The company was founded in 1903 and is based in Perth, Australia. Patersons Securities was acquired by Canaccord Genuity (Australia) Ltd. on October 21, 2019 for $17.42 million. | Corporate Officer/Principal | - |
Training of Steven Yatomi-Clarke
| University of Melbourne | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| PRESCIENT THERAPEUTICS LIMITED | Health Technology |
| Private companies | 1 |
|---|---|
Patersons Securities Ltd.
Patersons Securities Ltd. Investment Banks/BrokersFinance Patersons Securities Ltd. is a brokerage firm that provides brokerage services. The company was founded in 1903 and is based in Perth, Australia. Patersons Securities was acquired by Canaccord Genuity (Australia) Ltd. on October 21, 2019 for $17.42 million. | Finance |
- Stock Market
- Insiders
- Steven Yatomi-Clarke